Organized in collaboration with the SQN : Saturday October 5th and Sunday, October 6th, 2024
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and a Recognized Professional Development Activity (Category A) as defined by the Collège des médecins du Québec. This activity was approved by the direction de Développement professionnel continu (DDPC) of the Fédération des médecins spécialistes du Québec.
You may claim a maximum of 7.5 Accredited Group Learning Activity (Section 1) / Recognized Professional Development Activity (Category A) hours. Participants must claim a number of hours consistent with their attendance.
***NOTE: F.E.N. 2024 is a full-day CME activity. Unlike the 22nd ANNUAL CONFERENCE OF FONDATION D.E.V.E.N.I.R., participants will only be able to register and attend the entire educational program F.E.N.***
Dr. Daniel Garceau
Dr. Brad Rovin
Professor of Medicine and Pathology
The Lee A. Hebert Professor of Nephrology
Director, Division of Nephrology
Medical Director, Wexner Medical
Center for Clinical Research Management
Columbus, OH, USA
Dr. Johannes Münch
Chief of Nephrology
Department of Nephrology
University of Leipzig Medical Center
Leipzig, Germany
Using clinical cases
Dr. Debbie L. Cohen
Professor of Medicine
Director of Hypertension Programs
Director of Pheochromocytoma/Paraganglioma Programs
Perelman School of Medicine,
University of Pennsylvania
PA, USA
Dr. Daniel Garceau
Dr. Sanjeev Sethi
Professor
Mayo Clinic
Rochester, MN, USA
Dr. Biff F. Palmer
Professor of Internal Medicine
Department of Internal Medicine
Division of Nephrology
UT Southwestern Medical Center
Dallas, TX, USA
Using clinical cases
Dr. William Beaubien-Souligny
Nephrologist
Clinical Researcher
Adjunct Clinical Professor
CRCHUM
CHUM
Université de Montréal
Montréal, QC, Canada
Dr. Daniel Garceau
Note: This program receives unrestricted educational grant from pharmaceutical company Amgen Canada, without any regards to the choice of speakers, topics, choice of members of the scientific committee. We offer our thanks to Amgen Canada as exhibitor.